Thalidomide-O-amido-C3-NH2 (TFA) manufacturers
|
| | Thalidomide-O-amido-C3-NH2 (TFA) Basic information |
| Product Name: | Thalidomide-O-amido-C3-NH2 (TFA) | | Synonyms: | Thalidomide-O-amido-C3-NH2 (TFA);E3 Ligase Ligand-Linker Conjugates 52 (TFA);Thalidomide-O-amido-C3-NH2;Pomalidomide Related Compound 3 Triflate;N-(3-Aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide trifluoroacetic acid salt;N-(3-aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide;N-(3-aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide(TFA);N-(3-Aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate | | CAS: | 2022182-58-5 | | MF: | C20H21F3N4O8 | | MW: | 502.4 | | EINECS: | | | Product Categories: | | | Mol File: | 2022182-58-5.mol |  |
| | Thalidomide-O-amido-C3-NH2 (TFA) Chemical Properties |
| storage temp. | 2-8°C, sealed storage, away from moisture | | form | Solid | | color | White to off-white |
| | Thalidomide-O-amido-C3-NH2 (TFA) Usage And Synthesis |
| Uses | Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | | IC 50 | Cereblon | | References | [1] Lohbeck J, et al. Practical synthesis of a phthalimide-based Cereblon ligand to enable PROTAC development. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5260-5262. DOI:10.1016/j.bmcl.2016.09.048 |
| | Thalidomide-O-amido-C3-NH2 (TFA) Preparation Products And Raw materials |
|